Laser rigenerativo vulvo – vaginale

Laser rigenerativo vulvo – vaginale: quando, come e perchè

Filippo Murina – Orcid

Servizio di Patologia del Tratto Genitale Inferiore, Ospedale V. Buzzi – Università degli Studi di Milano

filippomurina577@gmail.com


DOI: 10.53146/lriog1202114

Abstract

The use of lasers to treat gynaecological conditions including genitourinary syndrome of the menopause (GSM) has become increasingly popular over recent years. The evidence suggests laser therapy may be beneficial as a non-hormonal treatment in GSM. However, we do not know what the optimum treatment regime or interval is or what the role is for sexual hormones either before or in addition to laser treatment. It was demonstrated that a combination regimen of laser and ospemifene may improve clinical effectiveness. Application of the regenerative laser to the vestibule for vulvar pain and dyspareunia is a promising and safe treatment option in postmenopausal women with the use of appropriate parameters. Clinicians need to be aware of the limitations, risks and outcomes of laser therapy as well as the need for careful evaluation of women to ensure appropriate patient selection. Patients also need to be advised and counselled about realistic expectations of outcomes. Indiscriminate treatment of patients with little evaluation and assessment and counselling will lead to poor satisfaction outcomes and morbidity.

Keywords: laser; genitourinary syndrome of the menopause; dyspareunia; vulvar pain.


Presente in LRIOG Nr.1 – 2021

e-ISSN: 1824-0283


Scarica il pdf    download_pdf